The needs and the condition of multiple sclerosis medical care in Poland

Potemkowski, Andrzej

doi:10.15557/an.2015.0008

Cited by 3 publications

(3 citation statements)

References 6 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Uveitis can be the first symptom of multiple sclerosis (MS) [65–68]. In Poland, the prevalence of MS in the last 60 years has ranged from 37–91 per 100,000 depending on the region of the country [69]. In our retrospective study, uveitis associated with MS was more common than in other European countries, including the Netherlands, France, Germany, the UK, Spain, and Austria [23,33,36,38–41].…”

Section: Discussionmentioning

confidence: 99%

A Retrospective Observational Study of Uveitis in a Single Center in Poland with a Review of Findings in Europe

et al. 2018

View full text Add to dashboard Cite

BackgroundThis study aimed to review the causes, presentation, and clinicopathological associations of uveitis in a single department of ophthalmology in Poland, and to compare the findings with previously published studies from other European countries.Material/MethodsReview of local patient records between 2005–2015 identified patients diagnosed with uveitis. Data obtained included age, gender, imaging findings, and laboratory diagnostic findings. A literature review identified 24 publications from 1976–2017 that reported observational data from patients with uveitis in Europe. Statistical analysis compared the findings.ResultsBetween 2005–2015, 279 patients were diagnosed with uveitis (mean age, 38.3±15.3 years) (61.6% women) including unilateral uveitis (60.5%), with posterior uveitis (48.4%), anterior uveitis (26.5%), and intermediate uveitis (12.9%). A general etiology was established in 76.3% and included ocular-specific syndromes (31.8%), infection (27.9%), and an association with systemic disease (16.8%), but 23.6% were unclassifiable. Specific causes of uveitis included toxoplasmosis (17.9%), Fuchs uveitis (12.2%), white dot syndromes (WDS) (10.4%), sarcoidosis (6.1%), toxocariasis (6.1%), HLA-B27-associated acute anterior uveitis (AAU) (5.7%), multiple sclerosis (4.7%), ankylosing spondylitis (3.6%) and herpesvirus infection (2.5%). Data from 26 published studies (24,126 patients with uveitis) from 12 European countries showed that idiopathic uveitis was most common (36.6%); the identified causes included toxoplasmosis (9.4%), WDS (7.2%), and Fuchs uveitis (6.1%).ConclusionsIn a single ophthalmic center in Poland, and throughout Europe, the causes of uveitis are varied. Genetic, geographic, social and environmental factors are likely to affect the cause of uveitis in different populations.

show abstract

Section: Discussionmentioning

confidence: 99%

A Retrospective Observational Study of Uveitis in a Single Center in Poland with a Review of Findings in Europe

et al. 2018

View full text Add to dashboard Cite

show abstract

“…The prevalence documented in the following studies sustained the increasing number of diagnosed patients as well as the longer duration of the disease. In 1995 in the province of Szczecin -Northwest Poland, prevalence was calculated at 110,54/100,000 (13); the studies of 2005 data retrieved varied from 45-95/100,000 and the last survey inclusion criteria was defi nite MS according to McDonald criteria and restricted the evaluated patients to those living in Szczecin area (14,15).…”

Section: Poland Czech and Slovakia Hungary (Graphic 1)mentioning

confidence: 99%

Untitled

2015

Ro J Neurol.

View full text Add to dashboard Cite

Background. Multiple sclerosis (MS) has a variable clinical and pathological course and pace, which eventually turns over years of that progression into a major source of disability especially among young adults. The regional incidence and prevalence data course are of utmost interest (i.e they tend to be higher in Europe within the last decade) mirroring diagnosis improvement, earlier and better treatment choices and an improved physio-pathological insight as shown by most recent studies. (1) The incidence and prevalence data tend to be higher in Europe within the last decade and are explained by diagnosis improvement and earlier and better treatment solutions for the patients mirrored by most recent studies. (1)The objective of the present study is to assess data available concerning the prevalence of multiple sclerosis in Romania and in Central and Southeastern Europe in a regional view. Material and method. A literature search has been performed in PubMed, DIMDI, Web of Science, and Google Scholar to retrieve population based studies in Central and Eastern Europe and epidemiological reviews through years 1960-2015. We searched the term "MS" combined with one of the following: "epidemiology" or "incidence" or "prevalence". We also did a manual search of reference list of the relevant articles. Results. 38 studies met the inclusion criteria and were analyzed. The epidemiologic data available for Central and Eastern Europe during the period 1960-2015 support the heterogeneity both of this region's resident population and of the studies design, making any global data assessment diffi cult, with a questionable reliability, therefore justifying a newer reappraisal.

show abstract

“…In Europe, women are affected twice as often as men [ 2 ]. This may be related to the higher incidence of viral diseases in women or simply to the larger number of women in the population [ 3 ].…”

Section: Introductionmentioning

confidence: 99%

Effect of Whole-Body Cryotherapy on Oxidant–Antioxidant Imbalance in Women with Multiple Sclerosis

Ptaszek,

Podsiadło,

Adamiak

et al. 2023

JCM

View full text Add to dashboard Cite

The aim of the study was to investigate whether 20 whole-body cryotherapy treatments have an effect on oxidative–antioxidant imbalances in women with multiple sclerosis. Fifty women aged 30–55 were examined: study group—15 women with multiple sclerosis, subjected to whole-body cryotherapy; first control group—20 women with multiple sclerosis who did not receive cryotherapy intervention; second control group—15 healthy women who participated in cryotherapy treatments. Blood from the examined women was collected twice (before and after the series of 20 cryotherapy sessions). An insignificant increase in the total antioxidant capacity (study group: p = 0.706; second control group: p = 0.602) was observed after the whole-body cryotherapy intervention. After the series of cryotherapy sessions, the total oxidative status/total oxidative capacity value was insignificantly decreased among the multiple sclerosis patients (decrease by 14.03%, p = 0.495). In women with multiple sclerosis, no significant cryotherapy impact was demonstrated on changes in the oxidant–antioxidant imbalance or concentrations of nitric oxide, uric acid, or matrix metalloproteinase-9.

show abstract

The needs and the condition of multiple sclerosis medical care in Poland

Cited by 3 publications

References 6 publications

A Retrospective Observational Study of Uveitis in a Single Center in Poland with a Review of Findings in Europe

A Retrospective Observational Study of Uveitis in a Single Center in Poland with a Review of Findings in Europe

Untitled

Effect of Whole-Body Cryotherapy on Oxidant–Antioxidant Imbalance in Women with Multiple Sclerosis

Contact Info

Product

Resources

About